After long haul, cancer bill passes
A bipartisan cancer research bill—aimed at tackling the disease's most dangerous forms—has finally passed Congress after nearly six years of work. The Recalcitrant Cancer Research Act passed both chambers last week as part of the conference report on defense authorization bill. The bill will create scientific frameworks for addressing the most dangerous cancers.
- Senators Hear How Two-Midnight Rule Harms Patients, Hospitals
- 3 Management Lessons from a Supermarket Debacle
- Medicare Advantage Carriers See 'No Choice' But to Accept Cuts
- Physicians to Appeal 'Docs v. Glocks' Ruling in FL
- IOM Identifies GME Problems, Calls for Finance Changes
- Healthcare Costs Start With What We Eat
- Handshaking Spreads Germs. Get Over It.
- Revenue Cycles Get a Boost from Simple JPEG Files
- Hospitals Likely to Outsource ICD-10 at Launch
- Anatomy of 3 Health System Rebranding Efforts